Microbix Biosystems Inc. (TSX:MBX)

Microbix Biosystems Revenue

Microbix Biosystems had revenue of 4.06M CAD in the quarter ending June 30, 2026, with 16.91% growth. This brings the company's total for the last twelve months to 15.40M, down -27.13% year-over-year. In the fiscal year ending September 30, 2025, Microbix Biosystems had annual revenue of 18.59M, down -26.81%. That makes Microbix Biosystems the 36,880th largest company in the world by revenue and 660th in Canada.

• Revenue (ttm): 15.40M
• Revenue Growth: -27.13%
• P/S Ratio: 2.67
• Revenue / Employee: 154.00K
• Employees: 70
• Market Cap: 41.09M

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• Product Sales 21.31M 83.9%
• Licensing Fees and Royalties 4.09M 16.1%

By Geography

Chart

• North America 19.05M 75.0%
• Europe 6.01M 23.7%
• Other Foreign Countries 332.61K 1.3%

Fiscal year ended Sep 30, 2024 See the full Microbix Biosystems breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Sep 30, 2025	18.59M	-6.81M	-26.81%
Sep 30, 2024	25.39M	8.88M	53.77%
Sep 30, 2023	16.51M	-2.56M	-13.43%
Sep 30, 2022	19.08M	483.28K	2.60%
Sep 30, 2021	18.59M	8.07M	76.66%
Sep 30, 2020	10.52M	-2.89M	-21.53%
Sep 30, 2019	13.41M	901.78K	7.21%
Sep 30, 2018	12.51M	2.32M	22.82%
Sep 30, 2017	10.19M	668.66K	7.03%
Sep 30, 2016	9.52M	643.23K	7.25%
Sep 30, 2015	8.87M	477.12K	5.68%
Sep 30, 2014	8.40M	-	-

Data Sources: Fiscal.ai and S&P Global Market Intelligence Last updated: Aug 13, 2026

Revenue data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company. Revenue segment and geography data is provided by S&P Global Market Intelligence.

Update frequency:

Quarterly

Last checked:

Oct 29, 2026

Data Sources Report a data error